Ukraine to receive 1,500 drones from Latvia
Source: Latvia's Defence Minister Andris Sprūds on X (Twitter), as reported by European Pravda
Details: On Tuesday 1 April, Sprūds announced that Latvia will deliver a further 1,500 combat drones to Ukraine.
Quote: "Two Latvian companies will provide Ukraine with a total of 12,000 drones worth €17 million as part of an international coalition of drones in the first half of this year," he added.
Latvian supplies en route to Ukraine.
Photo: Sprūds on X
For reference: The drone coalition, led by the United Kingdom and Latvia, was established in January 2024 to enhance Ukraine's unmanned aerial vehicle capabilities.
Background:
On 24 March, it was reported that the coalition had allocated €20 million from a joint fund to procure tactical-level reconnaissance drones for the Ukrainian defence forces.
On 28 March, the Swedish government directed its Armed Forces to contribute funds to coalitions focused on mine clearance and unmanned aerial vehicles under the Ramstein support framework for Kyiv.
Support Ukrainska Pravda on Patreon!
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
USA Today
10 minutes ago
- USA Today
Putin stalls. Trump changes his mind. Ukraine targets Moscow. Latest on the war.
Russian President Vladimir Putin is stalling over a ceasefire. The White House has changed its mind about sending weapons to Ukraine. A major Ukrainian drone attack on Russia sowed chaos at airports serving Moscow. Russia's summer offensive in Ukraine has seen Moscow make its largest territorial gains in Ukraine since the start of the year, according to the Ukrainian open-source DeepState website and estimates by the Institute for the Study of War, a think tank in Washington, D.C., that specializes in military affairs and warfare. In the past month, Russian military units concentrated in Ukraine's Sumy region, which borders Russia in the northeast, the eastern cities of Pokrovsk and Kostyantynivka, and Zaporizhzhia in the south, have gained about 200 square miles, according to data from the war study institute. That's an area a little larger than the size of Atlanta. Does that mean Russia is prevailing? Not really. It's not that simple. Here's the latest on Russia's war in Ukraine. Why is Russia gaining ground in Ukraine? Ukraine has liberated about 7% of the territory Russia occupied before and after Moscow's full-scale invasion in February 2022, according to Ukrainian estimates and DeepState. That leaves about 19% still in Russian hands. Moscow still controls Crimea, which it annexed in 2014, and about two-thirds of Ukraine's Donetsk region, a vast and heavily industrialized region which remains the center of the ground war. Russia has long had the upper hand in the war in terms of military manpower, but analysts say Moscow has suffered more casualties, and its loss of equipment − vehicles, artillery, tanks − also has been at a higher rate than Ukraine's. Though Russia has been advancing in recent months, those gains have been relatively slow and small, amounting to less than 0.1% of Ukraine's territory in July, according to a manual calculation. Still, one reason Russia may have been able to make progress, according to the war study institute, is that Russia has substantially increased its use of drone attacks, and missiles and shells, on Ukraine. These grew at an average monthly rate of 31% in June and July. Russia has been using drones to pin down Ukrainian troops. No, then yes, to more American weapons for Ukraine. Why? President Donald Trump began his second term promising to end the war in Ukraine in his first 24 hours in office. He quickly halted the flow of military aid to Kyiv and temporarily stopped sharing some intelligence. He also cast blame on Ukraine for the war, giving President Volodymyr Zelenskyy a public dressing down in the Oval Office when he tried to push back on that assertion and counter Trump by saying Putin was not a reliable negotiator. Since then, the leaders have revised their stances and welcomed more nuance in their discussions. The war is still raging. Trump has appeared to change his tune on Ukraine and Putin as the Russian leader has pushed forward with drone and missile attacks on Ukrainian cities and repeatedly rebuffed Trump's attempts to broker a ceasefire. In early July, Trump said he would resume shipping arms to Ukraine. He also announced a new arrangement with NATO that will see the military alliance transfer advanced U.S.-made air defense systems to Kyiv. He also altered his attitude about the Russian leader. "He's very nice to us all the time," Trump said July 9. "But it turns out to be meaningless." What about the diplomacy? Two rounds of Trump-brokered ceasefire talks between Ukraine and Russia have come to nothing. As the relationship between Putin and Trump has soured, a broad coalition of U.S. lawmakers has lined up ready to place new aggressive sanctions on Russia. Trump also has threatened "severe" economic penalties on Moscow if it does not commit to a ceasefire by early September. The Kremlin has dismissed this as "bluster." The Russian government has suggested that Trump and Putin could meet in Beijing in September when Russia's leader is there for the 80th anniversary of the end of World War II. Moscow said it had not heard whether Trump plans to attend. The White House has not commented. But there's little doubt Moscow, for now, is on the back foot geopolitically, and perhaps even militarily. Zelenskyy and French Foreign Minister Jean-Noel Barrot announced in Kyiv a series of manufacturing deals with French companies on July 21 that will launch drone production in Ukraine. Overnight, Russia launched its latest barrage of drones and missiles at Kyiv. But Ukraine is also fighting back in ways increasingly difficult for Moscow to ignore. Videos published by Russian media showed people sleeping on the floor of Sheremetyevo, Russia's busiest airport, amid long lines and canceled flights after Ukraine bombarded it with drones.
CNBC
11 minutes ago
- CNBC
AstraZeneca to invest $50 billion in the U.S. as pharma tariffs weigh
AstraZeneca on Monday said it plans to invest $50 billion in bolstering its U.S. manufacturing and research capabilities by 2030, becoming the latest pharmaceutical firm to ramp up its stateside spending in the wake of U.S. trade tariffs. The Anglo-Swedish biotech company, which is headquartered in Cambridge, England, said the "cornerstone" of the commitment would be a new multi-billion dollar facility to produce its weight management and metabolic portfolio, including its oral GLP-1 obesity pill. The facility, planned for the Commonwealth of Virginia, is set to be AstraZeneca's largest single manufacturing investment in the world and will "leverage AI, automation and data analytics to optimize production," the company said. The latest funding will also expand research and development and cell therapy manufacturing in Maryland, Massachusetts, California, Indiana and Texas, and create "tens of thousands of jobs," AstraZeneca added. CEO Pascal Soriot said the commitment underpins the firm's "belief in America's innovation in biopharmaceuticals" and would support its ambition to reach $80 billion in annual revenue by 2030, half of which is expected to come from the U.S. AstraZeneca, which made international headlines by developing one of the key Covid-19 vaccines, has long been prioritizing the U.S. market. The United States accounted for over 40% of the company's annual revenues in 2024. In November, shortly after the U.S. presidential election, AstraZeneca announced a $3.5 billion U.S. investment. Earlier this month, The Times reported that the firm may move its listing from London to the U.S., in what analysts said would be a major blow to the U.K.'s public markets. AstraZeneca is the most valuable business listed on London's FTSE 100. The company declined to comment on the Times report. AstraZeneca's funding announcement follows similar moves by global pharmaceutical firms — including Novartis, Sanofi and Roche and U.S.-headquartered Eli Lilly and Johnson & Johnson — who have all vowed over recent months to ramp up their U.S. investment amid U.S. President Donald Trump's demands to reshore domestic manufacturing. The industry is awaiting further clarity on the Trump administration's pharma tariffs, with the final outcome of a Section 232 investigation into the sector due at the end of this month. An effort to rebalance U.S. drug prices with those paid by other countries is also underway. Trump earlier this month suggested that the industry could face levies of up to 200%, with a brief 12-18 month grace period to allow firms to relocate manufacturing stateside. However, many firms and analysts have dubbed the time frame as insufficient. "Typically for most medicines it's a three to four year horizon. We're working very hard to accelerate that as fast as we can and demonstrate we're making the investments we have planned," Novartis CEO Vas Narasimhan said last week during an earnings call, adding that he hoped the administration would make allowances.
Yahoo
4 hours ago
- Yahoo
X Sees Revenue Boost After Launch of Latest AI Tools
This story was originally published on Social Media Today. To receive daily news and insights, subscribe to our free daily Social Media Today newsletter. With its advertising business still down on previous levels, and its audience slowly filtering away to other apps, how will Elon Musk's X continue to make money, and remain a viable proposition moving forward? That's been the key question since Musk purchased the app as his own social media hobby horse. In the months since, X/Twitter has suffered major losses from its core ad revenue, in response to Musk's controversial changes and personal stances. Indeed, X's advertising revenue, which pre-Elon made up 90% of its $5 billion annual intake, has declined by around 60%. And while Elon has also drastically cut staff, and reduced costs wherever he can, there remains a question as to how X will be able to rebuild its profitability, and get back on the right track, as its usage continues to slide. And also, now that Musk has turned on Trump, and alienated himself from at least some portion of Trump's audience. So how will X make money moving forward? The answer, at this stage, seems to be AI, with Musk moving to align all of his X investment behind his xAI push. Elon has long held an interest in AI development, and was one of the initial investors in OpenAI, back when the company was a non-profit, seeking the best ways to maximize AI's benefits for humanity. But Musk was ousted from the organization, after he sought to take over as its CEO. Then OpenAI released ChatGPT, and started making money from its systems, and Elon has held a grudge ever since, because it took millions in initial donations from him and has converted that into a business from which he gains no benefit. So, in some ways, Musk launched his own xAI project out of spite. But now, amid the broader AI hype, it's emerged as the central element of his re-imagined X business empire. So can X realign its revenue intake around AI, in order to reduce its reliance on ad dollars? Well, there's certainly something there. According to new data from AppFigures, the launch of xAI's Grok 4 model, which also includes more advanced access to paying subscribers, saw X's apps bring in a heap more money after the release. As reported by TechCrunch: 'Elon Musk's xAI launched Grok 4 late on July 9, and by Friday, July 11, Grok's gross revenue on iOS had jumped a whopping 325% to $419,000, up from $99,000 the day before the Grok 4 launch.' xAI's intake was largely focused on the separate Grok app, but with xAI also acquiring X the app, any income for X's AI projects is also now shared with X the platform in some way. Another element that also drove more interest was the launch of X's AI companions, including its 'anime goth girl' character, which users can engage in NSFW chats with. AppFigures data shows that Grok's iOS downloads increased by 40% the day after the launch of its AI companions, with revenue also rising. So maybe, if X can maximize interest in its AI offerings, that will offer a viable alternative to ad revenue, though ongoing concerns about X's AI model workings (the initial Grok 4 model incorporated Elon's personal opinions into its answers), as well as potential mental health issues related to AI companions, could impede this somewhat. I mean, those concerns aren't slowing X's development, which is now also targeting kids with its Grok AI bot offerings. But it does seem like xAI is veering into potentially dangerous territory, while the clear bias being built into the bot's answers also looks set to impede take-up in some circles. But maybe, xAI is becoming big enough to secure enough investment and capital to keep both xAI and X running. That'll be difficult in the longer term, because xAI will need to continue investing in its AI development to keep up with the competition, but right now at least, it does seem like novel applications are driving interest, as well as X's more advanced reasoning models. In this sense, the cult of Elon plays a key role in promoting xAI's tools as being cutting-edge, potentially groundbreaking AI models, based on Elon's direct involvement. Many still see Musk as a tech savant, who can see things that others cannot, and that may also be helping to generate more interest in his AI projects. But it remains a risky bet, and one that's likely to be superseded by larger, more well-funded AI projects, Yet, at the same time, X's business prospects have been looking up this year. According to Emarketer, X's global advertising revenue is projected to rise by 16.5% to $2.26 billion in 2025, as more brands come back to the platform, either based on the results of the U.S. election or pressure from X itself. Maybe, in combination, that could mean that X is in a stronger financial position than expected, with the billions invested into xAI also now available to be re-shared to the platform. And it's possible that X's AI projects could be enough to prop up its prospects, though it remains to be seen whether that initial interest in its AI tools will hold, and keep generating new income for the combined company. Sign in to access your portfolio
